Current status and challenges in the management of post-ablative hypothyroidism among Thai patients

• Conditions: Graves disease patients with post-ablative hypothyroidism receiving LT4 treatment for at least 6 months between 2016-2020; Radioiodine; Graves disease; Hypothyroidism; Levothyroxine

• Registration Number: TCTR20211108001
• Lead Sponsor: Theptarin Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-11-08
• Study Completion: 2022-01-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

Graves disease patients with post-ablative hypothyroidism receiving LT4 treatment for at least 6 months between 2016-2020
-Thai ethnicity

Exclusion Criteria

- Follow-up less than 6 months after RAI treament
- Not requiring LT4 treatment

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percentage of patients who achieved normal TSH status Last visit Percentage

Secondary Outcome Measures

Name	Time	Method
Factors associated with out-of-range TSH status Last visit Multivariate analysis